DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
L-ARABINOSE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
L-ARABINOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
UO2PIV2K4C
Molecule Type:
Small molecule
Molecular Formula:
C5H10O5
Molecular Weight:
150.13
AlogP:
-2.58
PSA:
90.15
HBD:
4.0
HBA:
#RotB:
0.0
Source:
LBS-008
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LBS-008
×
Maximum Phase:
1
First Approval:
None
UNII:
63WI9S8P1M
Molecule Type:
Small molecule
Molecular Formula:
C21H21F5N4O2
Molecular Weight:
456.42
AlogP:
3.63
PSA:
69.3
HBD:
1.0
HBA:
#RotB:
2.0
Source:
ANTI-SCLEROSTIN
1
Antibody
Investigational
Unknown
Unknown
Unknown
Sclerostin inhibitor
ANTI-SCLEROSTIN
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IGM-8444
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
IGM-8444
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BAY-1125976
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase AKT2 inhibitor
BAY-1125976
×
Maximum Phase:
1
First Approval:
None
UNII:
ZL7A1UM87X
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASTX660
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ASTX660
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-4769
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 inhibitor
AZD-4769
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C28H27NO3S
Molecular Weight:
457.6
AlogP:
6.7
PSA:
59.42
HBD:
1.0
HBA:
#RotB:
11.0
Source:
CP-609754
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Neoplasms
Unknown
CP-609754
×
Maximum Phase:
1
First Approval:
None
UNII:
L0S47W9GPY
Molecule Type:
Small molecule
Molecular Formula:
C29H22ClN3O2
Molecular Weight:
479.97
AlogP:
4.86
PSA:
60.05
HBD:
1.0
HBA:
#RotB:
4.0
Source:
AST-487
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Tyrosine-protein kinase receptor FLT3 inhibitor
AST-487
×
Maximum Phase:
1
First Approval:
None
UNII:
W34UO2M4T6
Molecule Type:
Small molecule
Molecular Formula:
C26H30F3N7O2
Molecular Weight:
529.57
AlogP:
5.11
PSA:
94.65
HBD:
3.0
HBA:
#RotB:
8.0
Source:
CETUXIMAB SAROTALOCAN
1
Antibody
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 binding agent
CETUXIMAB SAROTALOCAN
×
Maximum Phase:
1
First Approval:
None
UNII:
MG94W1I5XW
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-852927
1
Small molecule
Investigational
Unknown
Unknown
Hypercholesterolemia
LXR-alpha modulator
BMS-852927
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MOFAROTENE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Retinoid receptor modulator
MOFAROTENE
×
Maximum Phase:
1
First Approval:
None
UNII:
8K3CVY8F8V
Molecule Type:
Small molecule
Molecular Formula:
C29H39NO2
Molecular Weight:
433.64
AlogP:
6.31
PSA:
21.7
HBD:
0.0
HBA:
#RotB:
6.0
Source:
SAR-1349
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
SAR-1349
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KPT-8602
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
KPT-8602
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-2748
1
Small molecule
Investigational
Unknown
Unknown
Hepatitis C
Unknown
MK-2748
×
Maximum Phase:
1
First Approval:
None
UNII:
7YM030A71C
Molecule Type:
Small molecule
Molecular Formula:
C42H56N6O10S
Molecular Weight:
837.01
AlogP:
3.84
PSA:
204.33
HBD:
3.0
HBA:
#RotB:
8.0
Source:
SC-43
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SC-43
×
Maximum Phase:
1
First Approval:
None
UNII:
OT4AQX5MLU
Molecule Type:
Small molecule
Molecular Formula:
C21H13ClF3N3O2
Molecular Weight:
431.8
AlogP:
6.67
PSA:
74.15
HBD:
2.0
HBA:
#RotB:
4.0
Source:
RUXOTEMITIDE
1
Protein
Investigational
Unknown
Unknown
Carcinoma
Unknown
RUXOTEMITIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
75FBL12IZ7
Molecule Type:
Protein
Molecular Formula:
C78H106N18O9
Molecular Weight:
1439.82
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CYC065
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CYC065
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RUNIMOTAMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
RUNIMOTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FOLIGLURAX
1
Small molecule
Investigational
Unknown
Unknown
Parkinson Disease
Metabotropic glutamate receptor 4 positive allosteric modulator
FOLIGLURAX
×
Maximum Phase:
1
First Approval:
None
UNII:
FR50CP1D6W
Molecule Type:
Small molecule
Molecular Formula:
C23H23N3O3S
Molecular Weight:
421.52
AlogP:
4.26
PSA:
71.09
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CORDYCEPIN
1
Small molecule
Investigational
Unknown
Unknown
Leukemia
Unknown
CORDYCEPIN
×
Maximum Phase:
1
First Approval:
None
UNII:
GZ8VF4M2J8
Molecule Type:
Small molecule
Molecular Formula:
C10H13N5O3
Molecular Weight:
251.25
AlogP:
-0.95
PSA:
119.31
HBD:
3.0
HBA:
#RotB:
2.0
Source:
ATAMPARIB
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
ATAMPARIB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRICETAMIDE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Tyrosine-protein kinase JAK1 inhibitor
TRICETAMIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
V6X0RFU7AF
Molecule Type:
Small molecule
Molecular Formula:
C16H24N2O5
Molecular Weight:
324.38
AlogP:
1.31
PSA:
77.1
HBD:
1.0
HBA:
#RotB:
8.0
Source:
KB-004
1
Antibody
Investigational
Unknown
Unknown
Glioblastoma; Myelodysplastic Syndromes; Primary Myelofibrosis
Ephrin type-A receptor 3 inhibitor
KB-004
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIROCAFTOR
1
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis
Unknown
DIROCAFTOR
×
Maximum Phase:
1
First Approval:
None
UNII:
2G3T6M1AS9
Molecule Type:
Small molecule
Molecular Formula:
C22H28N2O3Si2
Molecular Weight:
424.65
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MK-8325
1
Unknown
Investigational
Unknown
Unknown
Hepatitis C, Chronic
Unknown
MK-8325
×
Maximum Phase:
1
First Approval:
None
UNII:
779TT17O5A
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-04991532
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Hexokinase type IV activator
PF-04991532
×
Maximum Phase:
1
First Approval:
None
UNII:
AJ212MS2O2
Molecule Type:
Small molecule
Molecular Formula:
C18H19F3N4O3
Molecular Weight:
396.37
AlogP:
3.76
PSA:
97.11
HBD:
2.0
HBA:
#RotB:
6.0
Source:
THIAMPHENICOL
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections
Unknown
THIAMPHENICOL
×
Maximum Phase:
1
First Approval:
None
UNII:
FLQ7571NPM
Molecule Type:
Small molecule
Molecular Formula:
C12H15Cl2NO5S
Molecular Weight:
356.23
AlogP:
0.4
PSA:
103.7
HBD:
3.0
HBA:
#RotB:
6.0
Source:
CVX-241
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
CVX-241
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PUQUITINIB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 inhibitor
PUQUITINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
WFG29AB872
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BTI-410
1
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
BTI-410
×
Maximum Phase:
1
First Approval:
None
UNII:
D5DS571AIS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OTX-008
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
OTX-008
×
Maximum Phase:
1
First Approval:
None
UNII:
8JI63CFH5V
Molecule Type:
Small molecule
Molecular Formula:
C52H72N8O8
Molecular Weight:
937.2
AlogP:
2.59
PSA:
166.28
HBD:
4.0
HBA:
#RotB:
24.0
Source:
SIRPIGLENASTAT
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SIRPIGLENASTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C22H27N5O5
Molecular Weight:
441.49
AlogP:
1.3
PSA:
153.76
HBD:
3.0
HBA:
#RotB:
11.0
Source:
MP-0250
1
Unknown
Investigational
Unknown
Unknown
Multiple Myeloma; Neoplasms
Unknown
MP-0250
×
Maximum Phase:
1
First Approval:
None
UNII:
UGI01OSA4N
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BOTENSILIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
BOTENSILIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
105
106
107
108
109
110
111
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA